Titre : Gènes switch

Gènes switch : Questions médicales fréquentes

Termes MeSH sélectionnés :

Research Design
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Gènes switch : Questions médicales les plus fréquentes", "headline": "Gènes switch : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Gènes switch : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-19", "dateModified": "2025-03-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Gènes switch" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Gènes régulateurs", "url": "https://questionsmedicales.fr/mesh/D005809", "about": { "@type": "MedicalCondition", "name": "Gènes régulateurs", "code": { "@type": "MedicalCode", "code": "D005809", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.024.340.425" } } }, "about": { "@type": "MedicalCondition", "name": "Gènes switch", "alternateName": "Genes, Switch", "code": { "@type": "MedicalCode", "code": "D005812", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Martin Fussenegger", "url": "https://questionsmedicales.fr/author/Martin%20Fussenegger", "affiliation": { "@type": "Organization", "name": "ETH Zürich, Department of Biosystems Science and Engineering, Mattenstrasse 26, 4058, Basel, Switzerland; University of Basel, Faculty of Life Science, Basel, Switzerland. Electronic address: fussenegger@bsse.ethz.ch." } }, { "@type": "Person", "name": "Ana Palma Teixeira", "url": "https://questionsmedicales.fr/author/Ana%20Palma%20Teixeira", "affiliation": { "@type": "Organization", "name": "ETH Zürich, Department of Biosystems Science and Engineering, Mattenstrasse 26, 4058, Basel, Switzerland." } }, { "@type": "Person", "name": "Jin Wang", "url": "https://questionsmedicales.fr/author/Jin%20Wang", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Physics and Applied Mathematics, State University of New York at Stony Brook, Stony Brook, New York 11794, USA." } }, { "@type": "Person", "name": "Jörg S Hartig", "url": "https://questionsmedicales.fr/author/J%C3%B6rg%20S%20Hartig", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, University of Konstanz, Universitätsstraße 10, 78457 Konstanz, Germany; Konstanz Research School Chemical Biology (KoRS-CB), University of Konstanz, Universitätsstraße 10, 78457 Konstanz, Germany. Electronic address: joerg.hartig@uni-konstanz.de." } }, { "@type": "Person", "name": "Omer Gokcumen", "url": "https://questionsmedicales.fr/author/Omer%20Gokcumen", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Building a Low-Cost Wireless Biofeedback Solution: Applying Design Science Research Methodology.", "datePublished": "2023-03-08", "url": "https://questionsmedicales.fr/article/36991630", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/s23062920" } }, { "@type": "ScholarlyArticle", "name": "Design, analysis, and interpretation of treatment response heterogeneity in personalized nutrition and obesity treatment research.", "datePublished": "2023-09-04", "url": "https://questionsmedicales.fr/article/37667550", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/obr.13635" } }, { "@type": "ScholarlyArticle", "name": "Bayesian analysis of single case experimental design count data in trauma research: A tutorial.", "datePublished": "2022-12-01", "url": "https://questionsmedicales.fr/article/36455884", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1037/tra0001357" } }, { "@type": "ScholarlyArticle", "name": "Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design.", "datePublished": "2024-05-07", "url": "https://questionsmedicales.fr/article/38713673", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0285635" } }, { "@type": "ScholarlyArticle", "name": "Exploring the design of clinical research studies on the efficacy mechanisms in type 2 diabetes mellitus.", "datePublished": "2024-09-20", "url": "https://questionsmedicales.fr/article/39371930", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2024.1363877" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Structures génétiques", "item": "https://questionsmedicales.fr/mesh/D040342" }, { "@type": "ListItem", "position": 4, "name": "Génome", "item": "https://questionsmedicales.fr/mesh/D016678" }, { "@type": "ListItem", "position": 5, "name": "Composants de génome", "item": "https://questionsmedicales.fr/mesh/D040481" }, { "@type": "ListItem", "position": 6, "name": "Gènes", "item": "https://questionsmedicales.fr/mesh/D005796" }, { "@type": "ListItem", "position": 7, "name": "Gènes régulateurs", "item": "https://questionsmedicales.fr/mesh/D005809" }, { "@type": "ListItem", "position": 8, "name": "Gènes switch", "item": "https://questionsmedicales.fr/mesh/D005812" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Gènes switch - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Gènes switch", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Gènes switch", "description": "Comment identifier un gène switch ?\nQuels tests sont utilisés pour les gènes switch ?\nLes gènes switch sont-ils visibles sur une analyse génétique ?\nPeut-on détecter des mutations dans les gènes switch ?\nQuels marqueurs sont associés aux gènes switch ?", "url": "https://questionsmedicales.fr/mesh/D005812?mesh_terms=Research+Design&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Gènes switch", "description": "Quels symptômes sont liés aux gènes switch ?\nLes gènes switch affectent-ils le développement ?\nPeut-on observer des anomalies dues aux gènes switch ?\nLes gènes switch influencent-ils le comportement ?\nY a-t-il des symptômes neurologiques associés ?", "url": "https://questionsmedicales.fr/mesh/D005812?mesh_terms=Research+Design&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Gènes switch", "description": "Peut-on prévenir les maladies liées aux gènes switch ?\nQuels modes de vie peuvent aider à prévenir ces maladies ?\nLes conseils génétiques sont-ils utiles ?\nY a-t-il des vaccins pour prévenir les effets des gènes switch ?\nComment le suivi médical contribue-t-il à la prévention ?", "url": "https://questionsmedicales.fr/mesh/D005812?mesh_terms=Research+Design&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Gènes switch", "description": "Comment traiter les dysfonctionnements des gènes switch ?\nLes traitements sont-ils personnalisés ?\nY a-t-il des essais cliniques pour ces traitements ?\nLes traitements sont-ils efficaces ?\nQuels effets secondaires peuvent survenir ?", "url": "https://questionsmedicales.fr/mesh/D005812?mesh_terms=Research+Design&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Gènes switch", "description": "Quelles complications peuvent survenir avec les gènes switch ?\nLes gènes switch peuvent-ils causer des maladies héréditaires ?\nY a-t-il des risques de transmission familiale ?\nLes complications sont-elles réversibles ?\nComment les gènes switch affectent-ils la longévité ?", "url": "https://questionsmedicales.fr/mesh/D005812?mesh_terms=Research+Design&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Gènes switch", "description": "Quels facteurs de risque sont associés aux gènes switch ?\nL'âge est-il un facteur de risque ?\nLe mode de vie influence-t-il les gènes switch ?\nLes facteurs génétiques jouent-ils un rôle ?\nLes infections peuvent-elles affecter les gènes switch ?", "url": "https://questionsmedicales.fr/mesh/D005812?mesh_terms=Research+Design&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier un gène switch ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'identification se fait par des techniques comme le séquençage et l'analyse d'expression génique." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour les gènes switch ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de PCR et des analyses de microarray sont couramment utilisés." } }, { "@type": "Question", "name": "Les gènes switch sont-ils visibles sur une analyse génétique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être détectés indirectement par l'expression des gènes qu'ils régulent." } }, { "@type": "Question", "name": "Peut-on détecter des mutations dans les gènes switch ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des mutations peuvent être identifiées par séquençage ciblé." } }, { "@type": "Question", "name": "Quels marqueurs sont associés aux gènes switch ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs épigénétiques comme les méthylations peuvent indiquer leur activité." } }, { "@type": "Question", "name": "Quels symptômes sont liés aux gènes switch ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient selon les gènes régulés, incluant des troubles métaboliques." } }, { "@type": "Question", "name": "Les gènes switch affectent-ils le développement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils jouent un rôle crucial dans le développement embryonnaire et cellulaire." } }, { "@type": "Question", "name": "Peut-on observer des anomalies dues aux gènes switch ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies peuvent se manifester par des malformations congénitales ou des cancers." } }, { "@type": "Question", "name": "Les gènes switch influencent-ils le comportement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains gènes switch peuvent affecter des traits comportementaux et cognitifs." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Certaines dysrégulations peuvent entraîner des troubles neurologiques variés." } }, { "@type": "Question", "name": "Peut-on prévenir les maladies liées aux gènes switch ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par le dépistage génétique et des interventions précoces." } }, { "@type": "Question", "name": "Quels modes de vie peuvent aider à prévenir ces maladies ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est bénéfique." } }, { "@type": "Question", "name": "Les conseils génétiques sont-ils utiles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les conseils génétiques aident à évaluer les risques et à planifier des actions préventives." } }, { "@type": "Question", "name": "Y a-t-il des vaccins pour prévenir les effets des gènes switch ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccins spécifiques pour les gènes switch." } }, { "@type": "Question", "name": "Comment le suivi médical contribue-t-il à la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier permet de détecter précocement des anomalies et d'intervenir rapidement." } }, { "@type": "Question", "name": "Comment traiter les dysfonctionnements des gènes switch ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et des médicaments ciblés peuvent être utilisés." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés en fonction du profil génétique du patient." } }, { "@type": "Question", "name": "Y a-t-il des essais cliniques pour ces traitements ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreux essais cliniques explorent des thérapies pour les gènes switch." } }, { "@type": "Question", "name": "Les traitements sont-ils efficaces ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité varie selon le type de gène switch et la pathologie associée." } }, { "@type": "Question", "name": "Quels effets secondaires peuvent survenir ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des effets secondaires peuvent inclure des réactions immunitaires ou des complications." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les gènes switch ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des cancers, des troubles métaboliques et des malformations." } }, { "@type": "Question", "name": "Les gènes switch peuvent-ils causer des maladies héréditaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains gènes switch sont impliqués dans des maladies héréditaires complexes." } }, { "@type": "Question", "name": "Y a-t-il des risques de transmission familiale ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les gènes switch peuvent être transmis et affecter plusieurs membres d'une famille." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles." } }, { "@type": "Question", "name": "Comment les gènes switch affectent-ils la longévité ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des dysfonctionnements peuvent réduire l'espérance de vie en augmentant le risque de maladies." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés aux gènes switch ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs environnementaux, génétiques et comportementaux peuvent influencer leur activité." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge peut affecter l'expression des gènes switch et le risque de maladies." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il les gènes switch ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme ou l'alimentation peuvent moduler leur activité." } }, { "@type": "Question", "name": "Les facteurs génétiques jouent-ils un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des variations génétiques peuvent prédisposer à des dysfonctionnements des gènes switch." } }, { "@type": "Question", "name": "Les infections peuvent-elles affecter les gènes switch ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent altérer l'expression des gènes switch et provoquer des maladies." } } ] } ] }

Sources (10000 au total)

Bayesian analysis of single case experimental design count data in trauma research: A tutorial.

Single case experimental designs (SCEDs) are suited to psychological trauma research that involves individualized treatments and where randomization might be impossible or inappropriate. However, SCED... Bayesian estimation allows flexible modeling of autocorrelations and distributions, works well for small samples, and provides easily interpretable estimates of uncertainty in the form of credible int... Bayesian estimates show superior performance over NAP estimates because they reflect the patterns in the data and account for distance between observations, unlike NAP. All the R programs are shared w... Through tutorials such as these, current and future researchers can be educated about Bayesian methodology, its appropriateness to address the idiosyncrasies posed by SCED count data, and aid further ...

Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design.

The prevalence, pathophysiology, and long-term outcomes of COVID-19 (post-acute sequelae of SARS-CoV-2 [PASC] or "Long COVID") in children and young adults remain unknown. Studies must address the urg... We describe the protocol for the Pediatric Observational Cohort Study of the NIH's REsearching COVID to Enhance Recovery (RECOVER) Initiative. RECOVER-Pediatrics is an observational meta-cohort study ... RECOVER-Pediatrics seeks to characterize the clinical course, underlying mechanisms, and long-term effects of PASC from birth through 25 years old. RECOVER-Pediatrics is designed to elucidate the epid... Clinical Trial Registration: http://www.clinicaltrials.gov. Unique identifier: NCT05172011....

Involving adolescents in the design, implementation, evaluation and dissemination of health research: an umbrella review protocol.

A lack of awareness on how to engage adolescents in research has been reported as one of the barriers to meaningful youth involvement in health research. Currently, available guidelines on youth invol... We will include review articles exploring adolescents' involvement in studies aiming to improve their physical or mental health. Databases to be searched include Cochrane Database of Systematic Review... Ethical approval is not required as we are not collecting participant data as part of this review. The findings of this umbrella review will be disseminated through peer-reviewed publications, partici... CRD42021287467....

Constructing Relative Effect Priors for Research Prioritization and Trial Design: A Meta-epidemiological Analysis.

Bayesian methods have potential for efficient design of randomized clinical trials (RCTs) by incorporating existing evidence. Furthermore, value of information (VOI) methods estimate the value of redu... We developed 2 Bayesian hierarchical models that captured variability in RTE between studies within disease area accounting for study characteristics. We illustrate the methods using a data set of 743... For most disease areas, the predicted RTE favored new interventions over comparators. The predicted effects and uncertainty differed across the 9 disease areas. VOI analysis showed that the expected v... This study demonstrates a novel approach to generating informative priors that can be used to aid research prioritization and trial design. The methods can also be used to combine RCT evidence with ex... Bayesian methods have potential to aid the efficient design of randomized clinical trials (RCTs) by incorporating existing evidence. Value-of-information (VOI) methods can be used to aid research prio...

The development of a set of key points to aid clinicians and researchers in designing and conducting n-of-1 trials.

n-of-1 trials are undertaken to optimise the evaluation of health technologies in individual patients. They involve a single patient receiving treatments, both interventional and control, consecutivel... The key points were developed by undertaking a stakeholder workshop, followed by a discussion within the study team and then a stakeholder dissemination and feedback event. The stakeholder workshop so... A set of 22 key points were developed based on the insights from the workshop and subsequent discussions. They provide guidance on when an n-of-1 trial might be a viable or appropriate study design an... The key points developed in the project will support clinical researchers to understand key considerations when designing n-of-1 trials. It is hoped they will support the wider implementation of the s...